None
Quote | Scholar Rock Holding Corporation (NASDAQ:SRRK)
Last: | $7.77 |
---|---|
Change Percent: | 0.13% |
Open: | $7.62 |
Close: | $7.77 |
High: | $8.07 |
Low: | $7.62 |
Volume: | 367,145 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | Scholar Rock Holding Corporation (NASDAQ:SRRK)
2024-06-24 09:22:18 ET More on Scholar Rock FOMC Meeting, Jobs Report, And Apple Earnings Headline Big Week Seeking Alpha’s Quant Rating on Scholar Rock Historical earnings data for Scholar Rock Financial information for Scholar Rock Read the...
2024-06-13 08:00:15 ET Etzer Darout from BMO Capital issued a price target of $31.00 for SRRK on 2024-06-13 07:24:00. The adjusted price target was set to $31.00. At the time of the announcement, SRRK was trading at $9.39. The overall price target consensus is at $28.50 ...
Message Board Posts | Scholar Rock Holding Corporation (NASDAQ:SRRK)
Subject | By | Source | When |
---|---|---|---|
znewcar1: SRRK 21% v2,1M c7.16 f51,6M H7.34 ML4.44 LL4.33 | znewcar1 | investorshangout | 07/06/2022 8:23:29 PM |
$SRRK...$34.75...on the 100ma break...:party: | georgie18 | investorshub | 11/11/2021 4:58:16 PM |
$SRRK...$28.45...Lets see if we can Break/Hold the Upper | georgie18 | investorshub | 11/04/2021 8:33:55 AM |
SRRK...$27.34...Bullish Doji Star Reversal Pattern to the Upside | georgie18 | investorshub | 10/29/2021 10:45:03 AM |
$SRRK...$31.62...on the 50ma Break to the Upside...:party: | georgie18 | investorshub | 06/14/2021 10:27:26 AM |
News, Short Squeeze, Breakout and More Instantly...
Scholar Rock Holding Corporation Company Name:
SRRK Stock Symbol:
NASDAQ Market:
Scholar Rock Holding Corporation Website:
2024-06-13 08:00:15 ET Etzer Darout from BMO Capital issued a price target of $31.00 for SRRK on 2024-06-13 07:24:00. The adjusted price target was set to $31.00. At the time of the announcement, SRRK was trading at $9.39. The overall price target consensus is at $28.50 ...
Promising objective response rates (ORR) were observed in multiple tumor types in anti-PD-(L)1 resistant patients Analysis of baseline biomarker data in clear cell renal cell carcinoma (ccRCC) patients reveals a doubling of the ORR highlighting a potential patient selection strategy ...
- Updated safety and efficacy results on SRK-181 will be featured in an oral presentation on Monday, June 3 rd , at 1:50 p.m CDT/2:50 p.m. EDT - Company will host conference call to discuss the data on Tuesday, June 4 th at 7:00 a.m. CDT/8:00 a.m. EDT Scholar Rock (NASDA...